CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation

Tissue structure and inflammatory processes shape viscoelastic properties of the mouse brain

(2015) Jason M. Millward et al.   NMR IN BIOMEDICINE

In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses

(2014) R. Winkler-Pickett et al.   JOURNAL OF IMMUNOLOGY

Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition

(2014) A. Lunemann et al.   JOURNAL OF IMMUNOLOGY

Ischemic neurons recruit natural killer cells that accelerate brain infarction

(2014) Y. Gan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

(2014) Cristina Limatola et al.   Frontiers in Cellular Neuroscience

Subsets of human natural killer cells and their regulatory effects

(2013) Binqing Fu et al.   IMMUNOLOGY

NK Cells in Central Nervous System Disorders

(2013) A. Poli et al.   JOURNAL OF IMMUNOLOGY

CX3CR1 Regulates the Maintenance of KLRG1+ NK Cells into the Bone Marrow by Promoting Their Entry into Circulation

(2013) A. Ponzetta et al.   JOURNAL OF IMMUNOLOGY

Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation

(2013) J. A. Garcia et al.   JOURNAL OF IMMUNOLOGY

The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse

(2013) Sebastian M. Fiebiger et al.   JOURNAL OF NEUROIMMUNOLOGY

Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy

(2013) Kevin R. Nash et al.   NEUROBIOLOGY OF AGING

Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients

(2013) Johan Mellergård et al.   PLoS One

The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications

(2013) Coralie Chanvillard et al.   Frontiers in Immunology

Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation

(2012) Isabell Hamann et al.   JOURNAL OF NEUROIMMUNOLOGY

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis

(2012) Coralie Chanvillard et al.   PLoS One

Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells

(2011) Isabell Hamann et al.   IMMUNOLOGY

CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells

(2011) Binqing Fu et al.   IMMUNOLOGY

Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients

(2011) T. A. Johnson et al.   JOURNAL OF IMMUNOLOGY

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

(2011) Mibel M Pabon et al.   Journal of Neuroinflammation

CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

(2010) Sungho Lee et al.   AMERICAN JOURNAL OF PATHOLOGY

Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology

(2010) Junwei Hao et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Maturation of mouse NK cells is a 4-stage developmental program

(2009) L. Chiossone et al.   BLOOD

Natural killer cells in human autoimmunity

(2009) Malin Flodström-Tullberg et al.   CURRENT OPINION IN IMMUNOLOGY

Unknown

(2009) Anna Lunemann et al.   MOLECULAR MEDICINE

Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues

(2008) A. E. Cardona et al.   BLOOD

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

(2008) J. R. Pallandre et al.   BLOOD